TP53 and hepatocellular carcinoma: It must also be considered that the downregulation of the AMPKa2 catalytic subunit is present in undifferentiated HCC, and AMPK inactivation promotes hepatocarcinogenesis by destabilizing p53 in a p53 deacetylase- and a SIRT1-dependent manner [132].